IP Library › Granted Patent US 10,017,744
Granted Patent B2
US 10,017,744 · App. 15/588,062 · Granted Jul 10, 2018

Methods for reprogramming somatic cells

Inventors: Rudolf Jaenisch (Brookline, MA); Konrad Hochedlinger (Cambridge, MA)
Assignee: WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
C12N5/0696C12N2501/602C12N2501/603C12N2501/605C12N2506/1307C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,017,744
App. No.
15/588,062
Granted
Jul 10, 2018
Kind
B2
Abstract

The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.

Claims (13)

1. A method of making a somatic cell more susceptible to reprogramming to a cell having a less differentiated state, comprising:

obtaining a somatic cell that comprises an exogenously introduced polynucleic acid encoding Oct4 protein, and an exogenously introduced polynucleic acid encoding Sox2 or Nanog protein;

wherein the exogenously introduced polynucleic acids result in making the somatic cell more susceptible to reprogramming to a less differentiated state.

2. The method of claim 1 , the step of obtaining further comprises:

introducing an exogenous polynucleic acid encoding Oct4 protein, and an exogenously introduced polynucleic acid encoding Sox2 or Nanog protein into the somatic cell; wherein one or both of the polynucleic acids is operatively linked to at least one heterologous regulatory sequence.

3. The method of claim 1 or 2 , further comprising:

contacting the somatic cell with a candidate agent of interest with respect to its potential to reprogram a somatic cell.

4. The method of claim 3 , wherein the candidate agent of interest is a DNA methylation inhibitor, a histone deacetylase inhibitor or PD098059.

5. The method of claim 1 , wherein the exogenous polynucleic acids increase Oct4 expression in the somatic cell.

6. The method of claim 1 , wherein the somatic cell is a mammalian cell.

7. The method of claim 1 , wherein the somatic cell is a human cell or a mouse cell.

8. The method of claim 1 , wherein the somatic cell is an adult stem cell.

9. The method of claim 8 , wherein the adult stem cell is selected from the group consisting of: a hematopoietic stem cell, a neural stem cell, and a mesenchymal stem cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2018
From: JAENISCH, RUDOLF; HOCHEDLINGER, KONRAD
To: WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 045690/0608 →
Continuity (7)
Continuation 14923321 · Oct 26, 2015
Continuation 13646430 · Oct 5, 2012
Continuation 12703061 · Feb 9, 2010
Division 10997146 · Nov 24, 2004
Provisional Application 60525612 · Nov 26, 2003
Provisional Application 60530042 · Dec 15, 2003
Related Publication 20170240865A1 · Aug 24, 2017